According to the BBJ, CutisPharma, a compounding company, has raised $20 million in equity financing.

CutisPharma is the industry leader in bringing innovation to the pharmaceutical compounding market. We aim to achieve the transformation of prescription compounding with high-quality products manufactured under strict compliance standards that increase the accuracy, quality, and efficiency of compounded prescriptions dispensed to patients.